Kirkland Advises Kestra Medical Technologies, Ltd. on Upsized Primary Public Offering of Common Shares
Kirkland & Ellis advised Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, on its upsized underwritten public offering of 6.9 million common shares at a price to the public of $23.00 per share, for total proceeds of $158.7 million. The offering closed on December 4, 2025.
The Kirkland team included capital markets lawyers Sophia Hudson, Christie Mok, Sandy Park and Clara Lang; technology & IP transactions lawyer Matt Darch; tax lawyer Leah Warren; and investment funds regulatory lawyer Phil Giglio.
